Trading / Browse Companies / Viridos Stock

Viridos Stock

viridos.comEnergyFounded: 2005Funding to Date: $276.94MM

Viridos a biotechnology company harnessing the power of algae to make renewable, low carbon and energy dense liquid fuels for heavy duty transportation applications.

Buy or sell Viridos stockLearn more about Viridos IPO
Register for Details

For more details on financing and valuation for Viridos, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Viridos.

Register Today

Team

Management Team

Hamilton Smith Ph.D
Co-Founder, Board Member & Chief Scientific Officer
David Kiernan MD
Co-Founder & Board Member
Oliver Fetzer Ph.D
Board Member & Chief Executive Officer
Craig Venter Ph.D
Co-Founder & Scientific Advisor

Board Members

Alfonso Romo
Plenus
Edgardo Cantu
Kok-Thay Lim
Martine Rothblatt Ph.D
United Therapeutics
Tina Nova Ph.D
Barry Schuler
Draper Fisher Jurvetson Management
Derrik Huat
Gregory Lucier
Invitrogen
Oliver Fetzer Ph.D
Reinhard Ambros Ph.D
William McKee
Clyde Hutchison Ph.D
David Kiernan MD
Juan Enriquez
Excel Venture Management
Justin Adams
Shaun Healey
BP Ventures
Tan Thay
Genting Genomics

Other companies like Viridos in the Energy sector

Helion Energy
Sector
Energy
Last Round Est. Valuation
$3.6B
Sila Nanotechnologies
Sector
Energy
Last Round Est. Valuation
$3.36B
Northvolt
Sector
Energy
Last Round Est. Valuation
$11.75B
Rondo Energy
Sector
Energy
 
 
Universal Hydrogen
Sector
Energy
Last Round Est. Valuation
$243.33MM
Jetti Resources
Sector
Energy
 
 
TAE Technologies
Sector
Energy
Last Round Est. Valuation
$4.96B
Group14 Technologies
Sector
Energy
Last Round Est. Valuation
$2.89B
Form Energy
Sector
Energy
Last Round Est. Valuation
$1.84B

News

Synthetic Genomics 01/18/2017
Synthetic Genomics and ExxonMobil Renew Algae Biofuels Research Agreement
Synthetic Genomics, Inc. and ExxonMobil announced today that they have extended their agreement to conduct joint research into advanced algae biofuels after making significant progress in understanding algae genetics, growth characteristics and increasing oil production.
Synthetic Genomics 01/09/2017
Synthetic Genomics Launches Vmax™ Express, a Next-Generation Protein Expression Platform for the Biotech Industry
SAN DIEGO, Jan. 9, 2017 /PRNewswire/ -- Synthetic Genomics Inc. announced today that its subsidiary, SGI-DNA, has...
Synthetic Genomics 01/05/2017
Synthetic Genomics Announces Collaboration with Johnson & Johnson Innovation to Develop Novel Therapeutics Using Synthetic Genomics' Replicon RNA Technology
SAN DIEGO, Jan. 5, 2017 /PRNewswire/ -- Synthetic Genomics, Inc., announced today that it has entered a research and...

Trending Companies

Frequently Asked Questions